Here, we performed Digital Spatial Profiling (DSP) analysis on stage II/III CRC tumor biopsy samples from a phase II, randomized, controlled clinical trial (QUASAR II) to identify stage-specific cellular signatures to include immune cells and signaling patterns relative to activin co-localization in situ. The gene discussed is INHBE; the disease is colorectal carcinoma.